Sector
Agro ChemicalsOpen
₹1,269.45Prev. Close
₹1,263.1Turnover(Lac.)
₹367.7Day's High
₹1,301.35Day's Low
₹1,246.0552 Week's High
₹1,49052 Week's Low
₹825.05Book Value
₹188Face Value
₹10Mkt Cap (₹ Cr.)
2,521.68P/E
0EPS
0Divi. Yield
0.12Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 19.61 | 19.61 | 19.6 | 19.59 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 349.07 | 399.19 | 376.38 | 289.12 |
Net Worth | 368.68 | 418.8 | 395.98 | 308.71 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 676.56 | 554.87 | 522.22 | 367.58 |
yoy growth (%) | 21.93 | 6.25 | 42.06 | 23.33 |
Raw materials | -386.81 | -342.05 | -338.16 | -235.04 |
As % of sales | 57.17 | 61.64 | 64.75 | 63.94 |
Employee costs | -50.31 | -38.34 | -29.92 | -21.7 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 121.04 | 88.67 | 61.27 | 51.52 |
Depreciation | -34.41 | -25.71 | -23.22 | -14.67 |
Tax paid | -31.22 | -23.97 | -13.8 | -20.7 |
Working capital | 149.03 | 43.21 | -5.77 | -13.19 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 21.93 | 6.25 | 42.06 | 23.33 |
Op profit growth | 38.18 | 30.86 | 23.93 | 10.37 |
EBIT growth | 39.23 | 26.44 | 18.86 | 20.84 |
Net profit growth | 38.83 | 36.27 | 35.74 | 83.14 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 458.18 | 628.17 | 676.57 | 554.87 | 522.61 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 458.18 | 628.17 | 676.57 | 554.87 | 522.61 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 5.64 | 13.06 | 10.47 | 7.92 | 11.93 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
P I Industries Ltd PIIND | 3,835.3 | 33.6 | 58,155.07 | 384.4 | 0.39 | 1,626.3 | 572.19 |
UPL Ltd UPL | 542.6 | 45.73 | 40,746.74 | -10 | 0.18 | 1,248 | 100.32 |
Bayer CropScience Ltd BAYERCROP | 6,529.55 | 39.48 | 29,313.48 | 96 | 2.14 | 791.5 | 634.02 |
Sumitomo Chemical India Ltd SUMICHEM | 499.1 | 67.3 | 24,857.46 | 109.28 | 1.18 | 664.37 | 48.88 |
Dhanuka Agritech Ltd DHANUKA | 1,684.1 | 32.31 | 7,677.67 | 59.02 | 0.83 | 368.31 | 275.54 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive Director
Ashok V Hiremath
Chairman (Non-Executive)
N B Godrej
Non Executive Director
Balram Yadav
Independent Director
Vijay Kashinath Khot
Independent Director
Brahma Nand Vyas
Company Sec. & Compli. Officer
Tejashree Pradhan
Independent Director
Govindan Ramakrishna Rishinaradamangalam
Independent Director
Dhekne Vasant Nandkumar
Independent Director
Anjali Rajesh Gupta
Whole Time Director & CEO
Anurag Roy
Non Executive Director
BURJIS GODREJ
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Astec Lifesciences Ltd
Summary
Astec LifeSciences Ltd is a producer of agrochemicals and pharmaceutical intermediates. The company manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates. They are having manufacturing facilities located at two locations in Maharashtra, India comprising of three units viz. one unit at Dombivli, Maharashtra and two units at Mahad, Maharashtra (Unit 1 and Unit 2). They are exporting their products to East Asia, Europe, Middle East, and USA.The business of the company comprises of the two major segments, namely Agrochemicals and Pharmaceuticals. Under the Agrochemical segment, the company manufactures active ingredients, intermediates and formulations. Active ingredients are sold to crop protection formulators. Intermediates are supplied to technical grade product manufacturers. Formulations are sold in bulk quantities to companies engaged in retail marketing. Under the Pharmaceutical segment, the company carries out manufacturing of intermediates which are supplied to Active Pharma Ingredients (API) manufacturers.Astec LifeSciences Ltd was incorporated on January 25, 1994 as a private limited company with the name Urshila Traders Pvt Ltd. The company was originally promoted by Reena Bagai and Avita Fernandes. Their shareholding was purchased by Ashok Hiremath and Pratap Garud on February 11, 1994. In August 19, 1994, the name of the company was changed from Urshila Traders Pvt Ltd to Astec Chemicals Pvt Ltd.In August 1994, the company sta
Read More
The Astec Lifesciences Ltd shares price on N/A is Rs.₹1281 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Astec Lifesciences Ltd is ₹2512.07 Cr. as of 22 Jul ‘24
The PE and PB ratios of Astec Lifesciences Ltd is 0 and 6.73 as of 22 Jul ‘24
The 52-week high/low is the highest and lowest price at which a Astec Lifesciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Astec Lifesciences Ltd is ₹826.15 and ₹1488 as of 22 Jul ‘24
Astec Lifesciences Ltd's CAGR for 5 Years at 31.36%, 3 Years at -3.36%, 1 Year at -3.82%, 6 Month at 23.15%, 3 Month at 1.88% and 1 Month at -1.94%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.